Učitavanje...
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
OBJECTIVE: To update clinicians with an overview of empagliflozin for the treatment of type 2 diabetes mellitus (T2DM), with focus on use in combination regimens. METHODS: Keyword searches were conducted in the Medline database to identify literature reporting clinical trials of at least 12 weeks’ d...
Spremljeno u:
| Izdano u: | Int J Gen Med |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888761/ https://ncbi.nlm.nih.gov/pubmed/27307761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S100288 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|